2025
SJR Q2
JCR Q2 · 2,3
OA
8 matched articles
ESCI
Journal detail
International Journal of Nephrology and Renovascular Disease
- Publisher
- Dove Medical Press Ltd
- Country
- New Zealand · Pacific Region
- Type
- journal
- ISSN
-
11787058
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,6
- Quartile Q2
- H-Index 47
- Cites/doc 2,28
- Docs (3y) 90
- Cites (3y) 232
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,3
- 5Y JIF 2,7
- JCI 0,59
WoS indexes
- ESCI
Subject classification
Categories (SJR)
- Nephrology Q2
Areas
- Medicine
WoS categories
- Urology & Nephrology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,6 | 2,3 | 2,7 | 0,59 | Q3 | 47 |
| 2024 | Q2 | Q2 | 0,582 | 2,5 | 2,4 | 0,63 | Q3 | 42 |
| 2023 | Q2 | Q2 | 0,584 | 2,1 | 2,6 | 0,55 | Q3 | 42 |
| 2022 | Q2 | — | 0,504 | 2 | 2,7 | 0,54 | Q3 | 42 |
| 2021 | Q2 | — | 0,571 | — | — | 0,57 | Q3 | 42 |
| 2020 | Q2 | — | 0,846 | — | — | 0,63 | Q3 | 42 |
| 2019 | Q2 | — | 0,76 | — | — | — | — | 42 |
| 2017 | Q2 | — | 0,903 | — | — | — | — | 42 |
| 2016 | Q1 | — | 0,904 | — | — | — | — | 42 |
| 2015 | Q2 | — | 0,628 | — | — | — | — | 42 |
| 2014 | Q3 | — | 0,481 | — | — | — | — | 42 |
| 2013 | Q3 | — | 0,287 | — | — | — | — | 42 |
| 2012 | Q3 | — | 0,286 | — | — | — | — | 42 |
| 2011 | Q4 | — | 0,122 | — | — | — | — | 42 |
| 2010 | Q4 | — | 0,126 | — | — | — | — | 42 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | UROLOGY & NEPHROLOGY | ESCI | Q2 | Q3 | 61/134 |
| 2024 | UROLOGY & NEPHROLOGY | ESCI | Q2 | Q3 | 48/133 |
| 2023 | UROLOGY & NEPHROLOGY | ESCI | Q2 | Q3 | 58/126 |
| 2022 | UROLOGY & NEPHROLOGY | ESCI | — | Q3 | — |
| 2021 | UROLOGY & NEPHROLOGY | ESCI | — | Q3 | — |
| 2020 | UROLOGY & NEPHROLOGY | ESCI | — | Q3 | — |